Cargando…
Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-Raf(V600E)/KDR Inhibitors Using Docking and 3D-QSAR Approaches
Research and development of multi-target inhibitors has attracted increasing attention as anticancer therapeutics. B-Raf(V600E) synergistically works with vascular endothelial growth factor receptor 2 (KDR) to promote the occurrence and progression of cancers, and the development of dual-target drug...
Autores principales: | Liu, Hai-Chun, Tang, San-Zhi, Lu, Shuai, Ran, Ting, Wang, Jian, Zhang, Yan-Min, Xu, An-Yang, Lu, Tao, Chen, Ya-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632759/ https://www.ncbi.nlm.nih.gov/pubmed/26501259 http://dx.doi.org/10.3390/ijms161024451 |
Ejemplares similares
-
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
por: Li, Yisu, et al.
Publicado: (2016) -
3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors
por: Fang, Yajing, et al.
Publicado: (2016) -
Reliable Functionalization of 5,6‐Fused Bicyclic N‐Heterocycles Pyrazolopyrimidines and Imidazopyridazines via Zinc and Magnesium Organometallics
por: Kumar Rout, Saroj, et al.
Publicado: (2022) -
Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023) -
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)